Implantable drug-eluting devices offer several unique advantages over conventional oral or parenteral drug delivery methods.
This report contains market size and forecasts of Implantable Drug-Eluting Devices in global, including the following market information:
Global Implantable Drug-Eluting Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Implantable Drug-Eluting Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Implantable Drug-Eluting Devices companies in 2021 (%)
The global Implantable Drug-Eluting Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Implantable Drug Infusion Pumps Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Implantable Drug-Eluting Devices include Pfizer, Medtronic, Merck, Bayer AG, Johnson & Johnson, Abbott, Surmodics, Boston Scientific Corporation and Titan Pharmaceuticals, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Implantable Drug-Eluting Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Implantable Drug-Eluting Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Implantable Drug-Eluting Devices Market Segment Percentages, by Type, 2021 (%)
Implantable Drug Infusion Pumps
Intraocular Drug-Eluting Devices
Contraceptive Drug-Eluting Devices
Drug-Eluting Stents
Others
Global Implantable Drug-Eluting Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Implantable Drug-Eluting Devices Market Segment Percentages, by Application, 2021 (%)
Diabetes
Contraception
HIV/AIDS Prevention
Chronic Pain Management
Cardiovascular
Ophthalmology
Oncology
Others
Global Implantable Drug-Eluting Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Implantable Drug-Eluting Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Implantable Drug-Eluting Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Implantable Drug-Eluting Devices revenues share in global market, 2021 (%)
Key companies Implantable Drug-Eluting Devices sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Implantable Drug-Eluting Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Medtronic
Merck
Bayer AG
Johnson & Johnson
Abbott
Surmodics
Boston Scientific Corporation
Titan Pharmaceuticals, Inc.
BIOTRONIK
Allergan
Bausch & Lomb
REVA Medical
MicroPort Medical